Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) EPS (Basic) (2016 - 2026)

Apyx Medical filings provide 16 years of EPS (Basic) readings, the most recent being -$0.03 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 75.0% to -$0.03 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.27, a 59.7% increase, with the full-year FY2025 number at -$0.27, up 59.09% from a year prior.
  • EPS (Basic) hit -$0.03 in Q4 2025 for Apyx Medical, up from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.03 in Q2 2023 to a low of -$0.28 in Q4 2023.
  • Median EPS (Basic) over the past 5 years was -$0.12 (2021), compared with a mean of -$0.13.
  • Biggest five-year swings in EPS (Basic): soared 81.25% in 2023 and later tumbled 533.33% in 2024.
  • Apyx Medical's EPS (Basic) stood at -$0.06 in 2021, then tumbled by 183.33% to -$0.17 in 2022, then crashed by 64.71% to -$0.28 in 2023, then soared by 57.14% to -$0.12 in 2024, then skyrocketed by 75.0% to -$0.03 in 2025.
  • The last three reported values for EPS (Basic) were -$0.03 (Q4 2025), -$0.05 (Q3 2025), and -$0.09 (Q2 2025) per Business Quant data.